Adverum Mails Letter to Stockholders Highlighting World-Class Board of Directors Overseeing Successful ADVM-022 Commercial Launch

NEXT STORY
Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release
PREV STORY
NexImmune Appoints Chad Rubin as Senior Vice President, Corporate Affairs
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

398,245 Orion Corporation A shares converted into B shares

ORION CORPORATION      STOCK EXCHANGE RELEASE 19 APRIL 2017 at 9.00 a.m. EEST               398,245 ...

author_avatar
NASDAQ Market News

Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements 

-- Initiated Phase 1/2 clinical trial of MRT5005 in patients with cystic fibrosis ---- ...

author_avatar
NASDAQ Market News

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

author_avatar
NASDAQ Market News